Shanghai Fosun Pharmaceutical (Group) Co Ltd

Annual Report

Report overview

The report presents Fosun Pharma's 2023 group-wide sustainability performance across environmental, social and governance topics. It reports total carbon emissions of 960,864 ton CO2e, comprising Scope 1 emissions of 210,819 ton CO2e, Scope 2 emissions of 677,874 ton CO2e and Scope 3 emissions of 72,171 ton CO2e. The company had 40,370 employees at period end. ESG oversight was Board-led through a three-tier structure comprising the Board, ESG Committee and ESG Working Group.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 26 March 2024
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Energy consumption
Water consumption
Waste
Employees
Women on the board
Workplace fatalities

Materiality

Assessment
Basis
Matrix

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services